KDM6B overexpression alone led to mild hematopoietic phenotypes, but the stimulation with pro-inflammatory agents (LPS or TLR pathways) resulted in significant hematopoietic defects and recapitulated features of CMML [89]. The gene discussed is KDM6B; the disease is chronic myelomonocytic leukemia.